The stressors/stimuli leading to senescence include telomere shortening due to replicative exhaustion (replicative senescence, RS), oncogene hyperactivation (oncogeneinduced senescence, OIS), tumor suppressor loss, damage to DNA or chromatin structure (including from anti-cancer therapy), developmental cues, mitochondrial dysfunction, reprogramming factors, oxidative stress, wound healing, cell-cell fusion, and certain cytokines (including the senescence-associated secretory phenotype itself [SASP]). Senescence arrest occurs mostly in the G 1 phase of the cell cycle, distinguishing it from G 0 -arrested quiescent cells. The arrest is mediated by cyclin-dependent kinase inhibitors and is dependent on the TP53 and pRB tumor suppressor pathways. The SASP modulates immune surveillance during development, tissue regeneration, and proand anti-tumoral responses and enhances cellular reprogramming. The composition of the SASP is stimulus-dependent and includes pro-and anti-inflammatory cytokines, chemokines, stemness factors, and matrix metalloproteinases.
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Causes and Characteristics of Cellular Senescence-Top Panel
The stressors/stimuli leading to senescence include telomere shortening due to replicative exhaustion (replicative senescence, RS), oncogene hyperactivation (oncogeneinduced senescence, OIS), tumor suppressor loss, damage to DNA or chromatin structure (including from anti-cancer therapy), developmental cues, mitochondrial dysfunction, reprogramming factors, oxidative stress, wound healing, cell-cell fusion, and certain cytokines (including the senescence-associated secretory phenotype itself [SASP] ). Senescence arrest occurs mostly in the G 1 phase of the cell cycle, distinguishing it from G 0 -arrested quiescent cells. The arrest is mediated by cyclin-dependent kinase inhibitors and is dependent on the TP53 and pRB tumor suppressor pathways. The SASP modulates immune surveillance during development, tissue regeneration, and proand anti-tumoral responses and enhances cellular reprogramming. The composition of the SASP is stimulus-dependent and includes pro-and anti-inflammatory cytokines, chemokines, stemness factors, and matrix metalloproteinases.
The archetypical senescence biomarker is acidic lysosomal SA-ßGal activity, indicative of augmented autophagy and enlargement of the lysosomal compartment. Senescent cells undergo changes in chromatin architecture epitomized by the appearance of senescence-associated heterochromatin foci (SAHF), regions of condensed chromatin containing repressive histone marks. The formation of these foci depends on the CDKN2A-pRB pathway. The persistent DNA damage response (DDR) in senescent cells leads to senescence DNA damage foci (SDF) and telomere-dysfunction-induced foci (TIF). SDF and TIF are identified by the colocalization of DDR-associated proteins 53BP1, γH2AX, and ATM. Senescent cells also display distension of peri-and centromeric satellites (SADS). Senescent cells exhibit increased protein turnover and massive proteotoxic stress due to augmented autophagy and SASP component synthesis. This is partially explained by the colocalization of autophagic, lysosomal, and nascent proteins in the TOR-autophagy spatial coupling compartment, coupling protein catabolism and anabolism. Senescence is associated with increased rates of mitochondrial metabolic activity, including the tricarboxylic acid cycle, oxidative phosphorylation, and glycolytic pathways. Senescent cells have increased AMP/ADP:ATP and NAD + /NADH ratios, activating AMPK, which reinforces a TP53-dependent cell-cycle arrest. Senescent cells undergo notable changes in their extracellular matrix organization, which are reflected in their enlarged and flat morphology.
Regulation of the Cell Cycle Arrest-Middle Panel
Most senescence inducers activate the tumor suppressor pathways TP53/CDKN1A and/or pRB/CDKN2A. TP53 integrates signals for DNA-damage-induced senescence, imposing a CDKN1A-mediated cell-cycle arrest. DNA damage caused by genotoxic agents or reactive oxygen species (ROS) activates TP53 via the p38MAPK and ATM pathways. Generation of ROS occurs via tissue damage-activated RAC1, dysfunctional mitochondria, OIS, or SASP signaling. Dysfunctional mitochondria and other metabolic perturbations also induce a TP53-dependent arrest via AMPK activation. TP53-dependent upregulation of CDKN1A overrides the repression of the CDKN1A locus by Polycomb repressor complexes (PRC) 1 and 2, the long non-coding RNA PANDA, and the scaffolding factor hnRNPU. Additional regulation of the TP53-mediated senescence arrest occurs through acetylation by CBP and sumoylation by E3 SUMO ligase PIASγ .
During senescence, E2F7 and pRB act to repress pro-proliferation genes. E2F7 is a TP53 target gene and is the only E2F transcription factor (TF) family member that is strongly upregulated in senescence. The activity of pRB is tightly regulated by CDK-mediated phosphorylation. In senescence, CDK inhibitors, such as CDKN2A or −1A, maintain pRB in an active, hypophosphorylated state, leading to its association with and inhibition of E2F1-3, promoting the senescence arrest. E2F7 and pRB reinforce the repression of E2F target genes by promoting local heterochromatinization via the recruitment of histone deacetylases (HDACs), histone methyl transferases (HMTs), and PIASγ. The RNA interference machinery also contributes to the repression of a subset of E2F target genes. This is mediated by a microRNA (miR)-loaded AGO2 dimeric complex, which facilitates formation and binding of the pRB co-repressor complex to a subset of E2F targets to deposit repressive chromatin marks. In addition, OIS signaling through the MAPK pathway activates JunB-containing AP1 dimers to repress expression of CCND1 and strengthen the cell cycle arrest. Finally, increased promoter methylation, particularly flanking CpG islands, is associated with repression of cell cycle genes in senescence.
In proliferating cells, the INK4 locus (encoding for CDKN2A, -2B, and p14 ARF ) is maintained in a repressive chromatin state through lncRNA ANRIL-mediated recruitment of PRC1/2, catalyzing repressive histone methylation. Transcriptional activation of the CDKN2A gene and increased levels of CDKN2A are observed during senescence and aging, and thus, it is now considered an aging biomarker. The p14 ARF protein also contributes to senescence by stabilizing TP53 levels through inhibition of the HMDM2 ubiquitin ligase. Increased expression of the CDKN2B gene has been observed in developmentally programmed, SASP-mediated, DNA-damage-and oncogene-induced senescence. Increased levels of CDKN2B are dependent on TGF-β-SMAD and PI3K-FOXO signaling and IL6-mediated activation of C/EBPß. TP53-independent CDKN1A induction is central to developmentally programmed senescence. As with CDKN2B, CDKN1A induction during development is dependent upon TGF-β-SMAD and PI3K-FOXO signaling in the absence of detectable DNA damage. Increased levels of CDKN1B are also observed in this context. The mechanisms underlying the derepression of the INK4 locus include H3K27me3 demethylation, displacement of PRC complexes, and activation of TFs ETS1/2. In addition, ID proteins inhibit ETS TFs.
Regulation of the Inflammatory SASP-Bottom Panel
SASP induction relies on the activation of the inflammatory TFs NF-κB and C/EBPß, a chronic DNA damage response, and on the p38MAPK pathway. Many cis-regulatory regions of SASP genes contain NF-κB and C/EBPß binding sites, and their increased expression promotes a positive feedback loop that reinforces the senescent state through intra-, auto-, and paracrine signaling. In response to DNA damage, a DDR-activated PARP1-NF-κB axis induces the expression of a CCL2-dominated inflammatory SASP that confers metastatic properties in vivo. DDR-driven senescence involves stabilization of GATA4 by inhibiting its degradation through p62-mediated autophagy, which in turn leads to activation of NF-κB and transcription of inflammatory cytokines. OIS-induced SASP is dynamic, with an initial secretion dominated by NOTCH1, whose intracellular domain N1ICD restrains the inflammatory SASP by inhibiting the activity of C/EBPß. In this context, the super enhancer (SE) landscape is remodeled to facilitate the expression of inflammatory cytokines. This process requires the concerted binding of NF-κB and BRD4 at later stages of OIS, which promote activation of SASP-associated SEs. The NF-κB pathway is also activated through the RIG-I and IRF pathways in response to DNA damage. In this context, IRF3 contributes to the SASP by directly transcribing the IFNß gene. The majority of TFs involved in SASP transcriptional activation during development and reprogramming remain to be identified.
